CHRISTINE BOLLOM: Open Payments
NPI 1295366045 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 62 payments from 16 companies in 2025. Trend: 2023 $2,325 · 2024 $2,404 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $243 |
| ABBVIE INC. | 16 | $157 |
| Kowa Pharmaceuticals America, Inc. | 1 | $124 |
| Phathom Pharmaceuticals, Inc. | 2 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| Amgen Inc. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Abbott Laboratories | 2 | $49 |
| Lilly USA, LLC | 2 | $49 |
| PFIZER INC. | 2 | $37 |
Products named: Wegovy, ZORYVE, VOQUEZNA, VRAYLAR, JARDIANCE, Ozempic, GEMTESA, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
